HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Poole, R. B Articles by Arden, N. K Search for Related Content PubMed PubMed Citation Articles by Poole, R. B Articles by Arden, N. K Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Diabetes

A case of leg pain and weakness in a man with diabetes

¹ Royal Hampshire County Hospital, Winchester, UK
² University of Southampton, Southampton General Hospital, Southampton, UK

Correspondence to:
Dr Ruth B Poole
Royal Hampshire County Hospital, Romsey Road, Winchester SO22 5DG, UK; ruthpoole@doctors.org.uk 28 August 2005

Keywords: motor neurone disease; creatine kinase; diabetes

The first 150 words of the full text of this article appear below.

A 61-year-old man presented to his general practitioner in June 2001 with pain and weakness in both legs. He had a 31-year history of type 2 diabetes, treated with insulin for the previous 5 years. He had been treated with cerivastatin since October 2000 for hypercholesterolaemia. His serum creatine kinase (CK) was raised at 1040 IU/l (normal range 25–195). Renal function was normal. The cerivastatin was stopped. Two weeks later his CK had fallen to 734. A diagnosis of cerivastatin induced myositis was made.

In August 2001 he attended the diabetic clinic. He still had pain and weakness in his legs. He had felt well enough to go on a walking holiday in July. This had resulted in an elevation of his CK to 1033 although this had fallen to 770 by August. HbA1c was 6.9% and total:HDL cholesterol ratio was 3.9. The rise in CK was presumed to be . . . [Full text of this article]